Emaretamig is a humanized IgG1κ monoclonal antibody that selectively targets CLDN18 and CD3E. This compound exhibits significant anti-tumor efficacy and is primarily employed in research on gastric and pancreatic cancers. Its mechanism of action facilitates T-cell engagement with tumor cells, enhancing immune-mediated responses against malignancies expressing these antigens.
Emaretamig is a humanized IgG1κ monoclonal antibody that selectively targets CLDN18 and CD3E. This compound exhibits significant anti-tumor efficacy and is primarily employed in research on gastric and pancreatic cancers. Its mechanism of action facilitates T-cell engagement with tumor cells, enhancing immune-mediated responses against malignancies expressing these antigens.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
